In vivo measurements of the cerebral perfusion and cardiovascular effects of the novel guanidine ME10092 in the non-human primate, Papio ursinus.

[1]  T. Lundstedt,et al.  Synthesis and quantitative structure-activity relationship of hydrazones of N-amino-N'-hydroxyguanidine as electron acceptors for xanthine oxidase. , 2004, Journal of medicinal chemistry.

[2]  E. Ling,et al.  Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study , 2003, Neuropharmacology.

[3]  T. Lundstedt,et al.  The novel guanidine ME10092 protects the heart during ischemia-reperfusion. , 2002, European Journal of Pharmacology.

[4]  A. Matsuki,et al.  Alpha-2 Adrenoceptor Activity Affects Propofol-Induced Sleep Time , 2002, Anesthesia and analgesia.

[5]  Steven C. R. Williams,et al.  Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain , 2001, Brain Research.

[6]  A. Kiuru,et al.  N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical. , 2000, Archives of biochemistry and biophysics.

[7]  M. Dambrova,et al.  Cardioprotective effects of N‐hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats , 1999, British journal of pharmacology.

[8]  G. Ambrosio,et al.  Reperfusion injury: experimental evidence and clinical implications. , 1999, American heart journal.

[9]  J. Wikberg,et al.  Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranes. , 1998, Biochemical pharmacology.

[10]  C. Welch,et al.  Identification of an N-hydroxyguanidine reducing activity of xanthine oxidase. , 1998, European journal of biochemistry.

[11]  M. Ovize,et al.  A fresh look at reperfusion injury. , 1998, Cardiovascular research.

[12]  G. Drummen,et al.  The use of cis-parinaric acid to measure lipid peroxidation in cardiomyocytes during ischemia and reperfusion. , 1997, Biochimica et biophysica acta.

[13]  F. Singelyn,et al.  A Minimum Dose of Clonidine Added to Mepivacaine Prolongs the Duration of Anesthesia and Analgesia After Axillary Brachial Plexus Block , 1996, Anesthesia and analgesia.

[14]  F. Singelyn,et al.  Adding Clonidine to Mepivacaine Prolongs the Duration of Anesthesia and Analgesia after Axillary Brachial Plexus Block , 1991, Regional Anesthesia & Pain Medicine.